BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun ZJ, Pan CE, Liu HS, Wang GJ. Anti-hepatoma activity of resveratrol in vitroWorld J Gastroenterol 2002; 8(1): 79-81 [PMID: 11833076 DOI: 10.3748/wjg.v8.i1.79] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 42] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Wei L, Wang Z, Jing N, Lu Y, Yang J, Xiao H, Guo H, Sun S, Li M, Zhao D, Li X, Qi W, Zhang Y. Frontier progress of the combination of modern medicine and traditional Chinese medicine in the treatment of hepatocellular carcinoma. Chin Med 2022;17:90. [PMID: 35907976 DOI: 10.1186/s13020-022-00645-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Thummala C, Pamuru RR. Plant therapeutics for hepatocellular carcinoma. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3 2022. [DOI: 10.1016/b978-0-323-99283-1.00015-x] [Reference Citation Analysis]
3 Moola AK, Renuka SG, Seenivasan HK, Manickam N, Peela S, Kumari BR. Curing of liver cancer: an update on the efficacy of bioactive compounds. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3 2022. [DOI: 10.1016/b978-0-323-99283-1.00009-4] [Reference Citation Analysis]
4 Ekambaram R, Saravanan S, Selvam N, Dharmalingam S. Statistical optimization of novel acemannan polysaccharides assisted TiO2 nanorods based nanofibers for skin cancer application. Carbohydrate Polymer Technologies and Applications 2021;2:100048. [DOI: 10.1016/j.carpta.2021.100048] [Reference Citation Analysis]
5 Aires V, Colin DJ, Doreau A, Di Pietro A, Heydel JM, Artur Y, Latruffe N, Delmas D. P-Glycoprotein 1 Affects Chemoactivities of Resveratrol against Human Colorectal Cancer Cells. Nutrients 2019;11:E2098. [PMID: 31487863 DOI: 10.3390/nu11092098] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
6 Tarhan S, Özdemir F, İncesu Z, Demirkan ES. Direct and protective effects of single or combined addition of vincristine and ε-viniferin on human HepG2 cellular oxidative stress markers in vitro. Cytotechnology 2016;68:1081-94. [PMID: 26228177 DOI: 10.1007/s10616-015-9863-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
7 Singh D, Upadhyay G, Srivastava RK, Shankar S. Recent advances in pancreatic cancer: biology, treatment, and prevention. Biochim Biophys Acta 2015;1856:13-27. [PMID: 25977074 DOI: 10.1016/j.bbcan.2015.04.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
8 Tameda M, Sugimoto K, Shiraki K, Inagaki Y, Ogura S, Kasai C, Yoneda M, Okamoto R, Yamamoto N, Takei Y, Ito M, Nobori T. Resveratrol sensitizes HepG2 cells to TRAIL-induced apoptosis. Anticancer Drugs 2014;25:1028-34. [PMID: 24892721 DOI: 10.1097/CAD.0000000000000128] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
9 Singh S, Singh PP, Roberts LR, Sanchez W. Chemopreventive strategies in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2014;11:45-54. [PMID: 23938452 DOI: 10.1038/nrgastro.2013.143] [Cited by in Crossref: 208] [Cited by in F6Publishing: 208] [Article Influence: 23.1] [Reference Citation Analysis]
10 Zhu SJ, Pan J, Zhao B, Liang J, Ze-Yu W, Yang JJ. Comparisons on enhancing the immunity of fresh and dry Cordyceps militaris in vivo and in vitro. J Ethnopharmacol 2013;149:713-9. [PMID: 23916792 DOI: 10.1016/j.jep.2013.07.037] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
11 Hu Y, Wang S, Wu X, Zhang J, Chen R, Chen M, Wang Y. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma. J Ethnopharmacol. 2013;149:601-612. [PMID: 23916858 DOI: 10.1016/j.jep.2013.07.030] [Cited by in Crossref: 121] [Cited by in F6Publishing: 112] [Article Influence: 12.1] [Reference Citation Analysis]
12 Raffoul JJ, Heydari AR, Hillman GG. DNA Repair and Cancer Therapy: Targeting APE1/Ref-1 Using Dietary Agents. J Oncol 2012;2012:370481. [PMID: 22997517 DOI: 10.1155/2012/370481] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
13 Bennett LL, Rojas S, Seefeldt T. Role of Antioxidants in the Prevention of Cancer. Journal of Experimental & Clinical Medicine 2012;4:215-22. [DOI: 10.1016/j.jecm.2012.06.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
14 Stagos D, Amoutzias GD, Matakos A, Spyrou A, Tsatsakis AM, Kouretas D. Chemoprevention of liver cancer by plant polyphenols. Food and Chemical Toxicology 2012;50:2155-70. [DOI: 10.1016/j.fct.2012.04.002] [Cited by in Crossref: 115] [Cited by in F6Publishing: 120] [Article Influence: 10.5] [Reference Citation Analysis]
15 Shankar S, Singh BN, Srivastava RK. Plant Polyphenols and Their Role in Cancer Prevention and Chemotherapy. Nutrition, Diet and Cancer 2012. [DOI: 10.1007/978-94-007-2923-0_10] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
16 Latruffe N, Delmas D, Lizard G, Tringali C, Spatafora C, Vervandier-fasseur D, Meunier P. Resveratrol against Major Pathologies. Bioactive Compounds from Natural Sources, Second Edition 2011. [DOI: 10.1201/b11196-11] [Reference Citation Analysis]
17 Gullett NP, Ruhul Amin AR, Bayraktar S, Pezzuto JM, Shin DM, Khuri FR, Aggarwal BB, Surh YJ, Kucuk O. Cancer prevention with natural compounds. Semin Oncol 2010;37:258-81. [PMID: 20709209 DOI: 10.1053/j.seminoncol.2010.06.014] [Cited by in Crossref: 326] [Cited by in F6Publishing: 348] [Article Influence: 25.1] [Reference Citation Analysis]
18 Parekh P, Motiwale L, Naik N, Rao KV. Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells. Exp Toxicol Pathol. 2011;63:167-173. [PMID: 20133117 DOI: 10.1016/j.etp.2009.11.005] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 4.2] [Reference Citation Analysis]
19 Bishayee A, Politis T, Darvesh AS. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma. Cancer Treat Rev. 2010;36:43-53. [PMID: 19910122 DOI: 10.1016/j.ctrv.2009.10.002] [Cited by in Crossref: 131] [Cited by in F6Publishing: 107] [Article Influence: 9.4] [Reference Citation Analysis]
20 Amin AR, Kucuk O, Khuri FR, Shin DM. Perspectives for cancer prevention with natural compounds. J Clin Oncol. 2009;27:2712-2725. [PMID: 19414669 DOI: 10.1200/jco.2008.20.6235] [Cited by in Crossref: 358] [Cited by in F6Publishing: 380] [Article Influence: 25.6] [Reference Citation Analysis]
21 Mann CD, Neal CP, Garcea G, Manson MM, Dennison AR, Berry DP. Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis. Eur J Cancer Prev. 2009;18:13-25. [PMID: 19077560 DOI: 10.1097/cej.0b013e3282f0c090] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 3.9] [Reference Citation Analysis]
22 Pezzuto JM. Resveratrol as an Inhibitor of Carcinogenesis. Pharmaceutical Biology 2008;46:443-573. [DOI: 10.1080/13880200802116610] [Cited by in Crossref: 64] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
23 Kirimlioglu V, Sozen H, Turkoglu S, Haberal M. Protective effect of resveratrol, a red wine constituent polyphenol, on rats subjected to portal vein thrombosis. Transplant Proc 2008;40:290-2. [PMID: 18261608 DOI: 10.1016/j.transproceed.2007.11.051] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
24 Notas G, Nifli A, Kampa M, Vercauteren J, Kouroumalis E, Castanas E. Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation. Biochimica et Biophysica Acta (BBA) - General Subjects 2006;1760:1657-66. [DOI: 10.1016/j.bbagen.2006.09.010] [Cited by in Crossref: 80] [Cited by in F6Publishing: 68] [Article Influence: 4.7] [Reference Citation Analysis]
25 Gao D, Zhang X, Jiang X, Peng Y, Huang W, Cheng G, Song L. Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice. Life Sci 2006;78:2564-70. [PMID: 16321402 DOI: 10.1016/j.lfs.2005.10.030] [Cited by in Crossref: 100] [Cited by in F6Publishing: 94] [Article Influence: 5.9] [Reference Citation Analysis]
26 Pezzuto J. Resveratrol as an Inhibitor of Carcinogenesis. Oxidative Stress and Disease 2005. [DOI: 10.1201/9781420026474.ch13] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Ghidoni R, Signorelli P. Resveratrol as an Antiproliferative Agent for Cancer. Oxidative Stress and Disease 2005. [DOI: 10.1201/9781420026474.ch4] [Reference Citation Analysis]
28 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2005; 13(14): 1737-1743 [DOI: 10.11569/wcjd.v13.i14.1737] [Reference Citation Analysis]
29 Zhou HB, Chen JJ, Wang WX, Cai JT, Du Q. Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice. World J Gastroenterol 2005; 11(2): 280-284 [PMID: 15633232 DOI: 10.3748/wjg.v11.i2.280] [Cited by in CrossRef: 69] [Cited by in F6Publishing: 74] [Article Influence: 3.8] [Reference Citation Analysis]
30 Delmas D, Rébé C, Micheau O, Athias A, Gambert P, Grazide S, Laurent G, Latruffe N, Solary E. Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells. Oncogene 2004;23:8979-86. [PMID: 15480430 DOI: 10.1038/sj.onc.1208086] [Cited by in Crossref: 147] [Cited by in F6Publishing: 149] [Article Influence: 7.7] [Reference Citation Analysis]
31 Lançon A, Delmas D, Osman H, Thénot JP, Jannin B, Latruffe N. Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process. Biochem Biophys Res Commun 2004;316:1132-7. [PMID: 15044102 DOI: 10.1016/j.bbrc.2004.02.164] [Cited by in Crossref: 116] [Cited by in F6Publishing: 121] [Article Influence: 6.1] [Reference Citation Analysis]
32 Liu JR, Yang BF, Chen BQ, Yang YM, Dong HW, Song YQ. Inhibition of β-ionone on SGC-7901 cell proliferation and upregulation of metalloproteinases-1 and -2 expression. World J Gastroenterol 2004; 10(2): 167-171 [PMID: 14716815 DOI: 10.3748/wjg.v10.i2.167] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
33 Tan B, Huang JF, Wei Q, Zhang H, Ni RZ. Anti-hepatoma effect and its mechanism of arsenic trioxide on experimental liver cancer. Shijie Huaren Xiaohua Zazhi 2004; 12(1): 32-37 [DOI: 10.11569/wcjd.v12.i1.32] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
34 Liu ZS, Tang SL, Ai ZL, Sun Q, Qian Q, He YM, Zhu ZC. Establishment of apoptotic model induced by hydroxyapatite nanoparticles in human hepatoma cell line BEL-7402. Shijie Huaren Xiaohua Zazhi 2003; 11(9): 1357-1361 [DOI: 10.11569/wcjd.v11.i9.1357] [Reference Citation Analysis]
35 Liu ZS, Tang SL, Ai ZL. Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human hepatoma BEL-7402 cells. World J Gastroenterol 2003; 9(9): 1968-1971 [PMID: 12970886 DOI: 10.3748/wjg.v9.i9.1968] [Cited by in CrossRef: 84] [Cited by in F6Publishing: 85] [Article Influence: 4.2] [Reference Citation Analysis]
36 Liu HS, Pan CE, Yang W, Liu XM. Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice. World J Gastroenterol 2003; 9(7): 1474-1476 [PMID: 12854144 DOI: 10.3748/wjg.v9.i7.1474] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 51] [Article Influence: 2.5] [Reference Citation Analysis]
37 Cheng H, Liu YF, Zhang HZ, Shen WA, Zhang J, Zhang J. In vivo antitumour activity of PBMCs via genetic modification of single-chain immunotoxin. Shijie Huaren Xiaohua Zazhi 2003; 11(6): 708-711 [DOI: 10.11569/wcjd.v11.i6.708] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
38 Lin LW, Lin XY, He YM, Gao SD, Lin XD. Biological characteristics of HCC by ultrasound-guided aspiration biopsy and its clinical application. World J Gastroenterol 2003; 9(5): 941-945 [PMID: 12717834 DOI: 10.3748/wjg.v9.i5.941] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
39 Zhou HB, Yan Y, Sun YN, Zhu JR. Resveratrol induces apoptosis in human esophageal carcinoma cells. World J Gastroenterol 2003; 9(3): 408-411 [PMID: 12632486 DOI: 10.3748/wjg.v9.i3.408] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 55] [Article Influence: 2.7] [Reference Citation Analysis]
40 Cheng H, Liu YF, Zhang HZ, Shen WA, Zhang J, Zhang J. In vitro cytotoxicity of PBMCs via genetic modification of single-chain immunotoxin. Shijie Huaren Xiaohua Zazhi 2003; 11(3): 281-284 [DOI: 10.11569/wcjd.v11.i3.281] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 Liu JR, Chen BQ, Yang YM, Wang XL, Xue YB, Zheng YM, Liu RH. Effect of apoptosis on gastric adenocarcinoma cell line SGC-7901 induced by cis-9, trans-11-conjugated linoleic acid. World J Gastroenterol 2002; 8(6): 999-1004 [PMID: 12439913 DOI: 10.3748/wjg.v8.i6.999] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 44] [Article Influence: 2.1] [Reference Citation Analysis]